angiotensin receptor blockers - Globe Thesis

Keyword [angiotensin receptor blockers] Result: 1 - 16 \| Page: 1 of 1
1.	A Study On The Expression Level Of LOX-1 In The Vascular Wall And Its Early Prevention Effect Of Different Drugs In Rabbits With Atherosclerosis
2.	The Role And Mechanism Of E-selectin In The Pathogenesis Of Stroke A Systematic Review Of Angiotensin Receptor Blockers In Preventing Stroke
3.	Effect Of Long-term RAAS Blockade On Cardiovascular Aldosterone Production In Rats With Congestive Heart Failure After Myocardial Infarction
4.	The Renoprotective Effect Of ACEI And ARBs In Patients With CKD
5.	Blockade Of The Renin-angiotensin System Reduces The Incidence Of Type2Diabetes In Patients At High Risk Of Cardiovascular Disease:a Meta Analysis
6.	Status Survey Secondary Prevention Of Coronary Heart Disease In Patients With Chinese Medicine
7.	Angiotensin Receptor Blockers Versus Amlodipine Therapy For Left Ventricular Hypertrophy: A Systematic Review
8.	The Effects Of Angiotensin Enzyme Inhibitors And Angiotensin Receptor Blockers Therapy On Contrast-Induced Nephropathy In Patients Undergoing PCI Or CAG
9.	The Pharmacological Research Of A New Angiotensin Ⅱ Receptor Blocker Tek-2 With High PPARγ Agonistic Activity
10.	Different Renin Patients With High Blood Pressure Research Of Optimal Blood Pressure Drugs
11.	Clinical Research Progress Of Angiotensin Receptor Blocker In Cardiovascular Disease
12.	Comparative Effectiveness Of Different Renin-Angiotensin System Blockers In Patients With Prior Stroke:a PRISMA-Compliant Network Meta-Analysis
13.	Application Acoustic Imaging Evaluation Of Angiotensin Receptor Blockers For DCM Left Ventricular Cavity Hemodynamic Effects
14.	Impact Of Beta-blockers And Angiotensin-converting Enzyme Inhibitors/angiotensin Receptor Blockers On Systemic Immune Response And Outcomes In Patients With Acute Ischemic Stroke
15.	Beyond the antihypertensive effect: ACE inhibitors and angiotensin receptor blockers
16.	Comparison of monotherapy with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in improving health outcomes among veteran patients with type 2 diabetes
<<First <Prev Next> Last>> Jump to